Catheter Precision (VTAK) Operating Expenses (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Operating Expenses data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Operating Expenses fell 26.95% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (up 65.41% YoY) and the FY2025 annual result came in at $21.9 million, up 88.44% from the prior year.
• Operating Expenses declined to $2.7 million in Q1 2026 per VTAK's latest filing, from $10.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $66.6 million in Q1 2023 and bottomed at $2.7 million in Q1 2024.
• The 5-year median for Operating Expenses is $3.7 million (2025), against an average of $8.3 million.
• The widest annual swing landed in 2023, when Operating Expenses jumped 1128.71%; it then slumped 95.95% in 2024.
• Tracing VTAK's Operating Expenses over 5 years: stood at $8.2 million in 2022, then slumped by 66.91% to $2.7 million in 2023, then grew by 17.33% to $3.2 million in 2024, then soared by 216.06% to $10.1 million in 2025, then slumped by 73.13% to $2.7 million in 2026.
• Per Business Quant, the three latest VTAK Operating Expenses figures stand at $2.7 million (Q1 2026), $10.1 million (Q4 2025), and $3.2 million (Q3 2025).

Peer Comparison